Pursuant to 17 CTR 240.24b-2, confidential information has been omitted in places marked “[***]" and has been filed separately with the Securities and Exchange Commission pursuant to a Confidential Treatment Application filed with the Commission....License Agreement • November 9th, 2007 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • California
This License Agreement (this “Agreement”) is entered into as of July 17, 2007 (the “Effective Date”), by and between SPECTRUM PHARMACEUTICALS, INC. (“Spectrum”), a Delaware corporation having offices at 157 Technology Drive, Irvine, CA 92618 and INDENA SPA (“Indena”), an Italian company having offices at Viale Ortles 12, 20139 Milano, Italy. Indena and Spectrum may each be referred to herein individually as a “Party” and collectively as the “Parties.”
FIRST AMENDMENT TO LICENCE AGREEMENT DATED AUGUST 28, 2001 BETWEEN JOHNSON MATTHEY PLC AND NEOTHERAPEUTICS, INC.License Agreement • November 9th, 2007 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations
This First Amendment to License Agreement (“FIRST AMENDMENT”) is entered into and effective this 30th day of September 2002 by and between Johnson Matthey PLC, a company organised under the laws of England and Wales whose registered office is at 2-4 Cockspur Street, Trafalgar Square, London, SW1Y 5BQ, England, acting for itself and for its AFFILIATES including particularly Johnson Matthey, Inc (collectively, “LICENSOR”), and NeoTherapeutics, Inc., a corporation organized under the laws of the State of California, United States of America whose principal place of business is at 157 Technology Drive, Irvine, California 92618, United States of America with reference to the following facts and on the following terms and conditions.
